Antibiotic combinations for enterococcus blood infection
Part of Blood & lymphatic, Infections clinical trials.
This study looks at whether using two or more antibiotics together works better than one alone for a specific type of blood infection caused by Enterococcus faecalis bacteria. The goal is to find the safest and most effective way to treat this infection and improve outcomes for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a blood infection caused only by Enterococcus faecalis bacteria (no other germs).
- You have taken at least one antibiotic (like ampicillin, vancomycin, or daptomycin) for 5 or more days, with or without a second drug.
- You agree to be part of the study and sign a consent form.
- You are not expected to pass away within the next 3 days from the infection.
- You do not have any other active infection besides the blood infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two antibiotics (cefepime and enmetazobactam) to treat complicated urinary tract infections that have spread to the blood. It aims to see if this new combination works better than other antibiotics and is safe for patients.
This study looks at how doctors can best manage antibiotics for a common type of blood infection (caused by Enterobacterales bacteria like E. coli). If you join, your treatment will be carefully guided to make sure you get the right antibiotics at the right time, which may help you recover faster and prevent antibiotic resistance.
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
This trial tests whether piperacillin-tazobactam works as well as meropenem to treat bloodstream infections caused by certain E. coli or Klebsiella germs that resist common cephalosporin antibiotics. It may help you avoid a “bigger” antibiotic if the study drug is equally effective.
This trial tests whether the antibiotic cefotetan works as well as current standard treatments for E. coli bloodstream infections that start in the urinary tract. If you qualify, you may receive either cefotetan or the usual antibiotic therapy.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Hear when a new Enterococcus Faecalis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.